FUTURESTITCH, INC. – Trademark Portfolio
Entity Type: 03
FUTURESTITCH, INC. holds 34 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 25 (Clothing) — 24 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 7 Nice Classification classes. Currently, 12 trademarks are registered and 10 are pending. Notable registered marks include HEAL, SOCKI, FRESHMD, BOOSOCKI, and FOOTNOTE. The owner is based in SAN CLEMENTE, CA.
144 Ave Serra
SAN CLEMENTE, CA 92673
Showing of trademarks Trademarks
Trademark Classifications
FUTURESTITCH, INC.'s trademark portfolio spans 7 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Education; providing of training; entertainment; sporting and cultural activities
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does FUTURESTITCH, INC. have?
FUTURESTITCH, INC. has 34 U.S. trademarks filed with the USPTO. Of these, 12 registered, 10 pending, 12 abandoned.
What trademark classes does FUTURESTITCH, INC. file in?
FUTURESTITCH, INC. files trademarks across 7 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 10 (Medical Apparatus), Class 16 (Paper Goods), Class 40 (Treatment & Processing), Class 41 (Education & Entertainment). Class 25 covers clothing, footwear, headgear.
What are FUTURESTITCH, INC.'s most well-known trademarks?
FUTURESTITCH, INC.'s registered trademark portfolio includes well-known marks such as HEAL, SOCKI, FRESHMD, BOOSOCKI, and FOOTNOTE. These are among 12 currently registered trademarks in the portfolio.
What is FUTURESTITCH, INC.'s trademark registration success rate?
FUTURESTITCH, INC. has a 50% trademark registration rate, with 12 out of 24 resolved applications resulting in successful registration. Currently, 10 applications are pending review.